Giulio Marchesini

About Giulio Marchesini

Giulio Marchesini, With an exceptional h-index of 114 and a recent h-index of 71 (since 2020), a distinguished researcher at Università degli Studi di Bologna, specializes in the field of metabolism, liver, diabetes, obesity.

His recent articles reflect a diverse array of research interests and contributions to the field:

A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study

Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity

Metformin and the Liver: Unlocking the Full Therapeutic Potential

Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus

MASLD emerging from the fog of fatty liver

Impact of migration on diabetes burden: audit in the metropolitan area of Bologna, Italy

Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply

NAFLD, the hepatic manifestation of the metabolic syndrome

Giulio Marchesini Information

University

Position

Professor of Medicine

Citations(all)

86250

Citations(since 2020)

36685

Cited By

62565

hIndex(all)

114

hIndex(since 2020)

71

i10Index(all)

414

i10Index(since 2020)

276

Email

University Profile Page

Google Scholar

Giulio Marchesini Skills & Research Interests

metabolism

liver

diabetes

obesity

Top articles of Giulio Marchesini

A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study

Nutrition, Metabolism and Cardiovascular Diseases

2024/5/1

Santo Colosimo
Santo Colosimo

H-Index: 1

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity

Acta Diabetologica

2024/4/29

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Maria Letizia Petroni
Maria Letizia Petroni

H-Index: 21

Metformin and the Liver: Unlocking the Full Therapeutic Potential

2024/3/25

Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus

International Journal of Molecular Sciences

2024/3/9

MASLD emerging from the fog of fatty liver

Journal of Hepatology

2024/2/1

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Massimo Pinzani
Massimo Pinzani

H-Index: 57

Impact of migration on diabetes burden: audit in the metropolitan area of Bologna, Italy

Journal of Endocrinological Investigation

2024/2

Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply

2024/1

NAFLD, the hepatic manifestation of the metabolic syndrome

2024/1/1

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Maria Letizia Petroni
Maria Letizia Petroni

H-Index: 21

Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting

Alimentary Pharmacology & Therapeutics

2024/1

Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

Diabetes Care

2023/7/1

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes

2023/6/13

Maria Letizia Petroni
Maria Letizia Petroni

H-Index: 21

Giulio Marchesini
Giulio Marchesini

H-Index: 67

should NAFLD be included in the definition of Metabolic Syndrome?

2023/5

Santo Colosimo
Santo Colosimo

H-Index: 1

Giulio Marchesini
Giulio Marchesini

H-Index: 67

Optimization of glucose control drives improvement of NAFLD independent of weight loss in people with T2D: Selected Abstract–Spring Meeting 2023

European Atherosclerosis Journal

2023/4/30

Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian …

Digestive and Liver Disease

2023/4/1

Corrigendum to ‘Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian …

Nutrition, Metabolism and Cardiovascular Diseases

2023/4/1

Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent

Nutrition, Metabolism and Cardiovascular Diseases

2023/3/1

Promoting weight loss and psychological well‐being in patients with obesity: A sequential combination of behavioural lifestyle intervention and well‐being therapy

Clinical Psychology & Psychotherapy

2023/3

Lifestyle intervention in NAFLD: long-term diabetes incidence in subjects treated by web-and group-based programs

Nutrients

2023/2/3

The treatment of diabetes in advanced liver disease: change of a paradigm

Annals of Hepatology

2023

Maria Letizia Petroni
Maria Letizia Petroni

H-Index: 21

Giulio Marchesini
Giulio Marchesini

H-Index: 67

See List of Professors in Giulio Marchesini University(Università degli Studi di Bologna)

Co-Authors

academic-engine